HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?
HQY's strong quarterly results and solid top-line growth raise optimism about the stock.
HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.
The mean of analysts' price targets for HealthEquity (HQY) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.